Healthy Aging Health Center
Exercise vs. Diets: Weighing the Benefit
Sept. 19, 2008 -- There's even more evidence that it is never too late to start exercising.
When overweight older people start walking or riding a stationary bike, they are able to improve their exercise efficiency, according to a new study. Exercise efficiency refers to using fewer calories to perform a physical activity.
Exercise Videos
Related Slideshows
Also, exercisers burn more fat and lose less muscle than older people who simply diet for weight loss. People tend to lose lean muscle mass as they age, and if they lose too much, it can interfere with the activities of daily living.
"The take-home message is that, even among older people and during a fairly short period of time, exercise produces metabolic changes that require the expenditure of fewer calories during physical activity. Exercise also allowed older people to more preferentially burn fat, which may be healthier metabolically," says researcher Bret Goodpaster, PhD, of the University of Pittsburgh, in a news release.
The study is published in the Journal of Applied Physiology. University of Pittsburgh researchers divided 64 sedentary participants, all between the ages of 60 and 75 and all either overweight or obese, into three groups. There were the dieters, the exercisers, and a group that both dieted and exercised for four months.
Dieters reduced their caloric intake enough to achieve a 10% weight loss by the end of the four-month study period. Exercisers could either walk, bike, or row three to five times a week for four months. Most of the exercisers chose to walk.
The exercise-only group increased efficiency compared to the diet-only group. The diet-and-exercise group also increased efficiency compared to the diet-only group.
As for burning fat, the exercisers again came out ahead. All three groups lost weight; the diet-only and diet-and-exercise groups lost more weight than the exercise-only group. The diet-only group lost more lean muscle and fat. The exercise-only and diet-and-exercise groups drew more on fat stores as an energy source.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


